EPID Multiple Sclerosis Pregnancy Study
Condition: Multiple SclerosisInterventions: Drug: Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG; Drug: Extavia (interferon beta-1b), Novartis Pharma AG; Drug: Rebif (interferon beta-1a), Merck Serono Europe Ltd; Drug: Plegridy (peginterferon beta-1a), Biogen Idec Ltd; Drug: Avonex (interferon beta-1a), Biogen Idec Ltd; Drug: MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046); Other: No MSDMDs therapy (control)Sponsors: Bayer; EPID Research; Biogen; Merck Serono Europe Ltd; Novartis PharmaceuticalsNot yet recruiting - verified April 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avonex | Betaseron | Merck | Multiple Sclerosis | Pharmaceuticals | Pregnancy | Rebif | Research | Study